Detalhe da pesquisa
1.
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities.
Ann Hematol
; 103(1): 117-123, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030891
2.
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia.
Am J Hematol
; 98(12): E360-E363, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37705256
3.
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
Cancer
; 128(19): 3495-3501, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942592
4.
Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
Eur J Haematol
; 104(5): 488-498, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31990086
5.
Validation of the Khorana score in acute myeloid leukemia patients: a single-institution experience.
Thromb J
; 17: 13, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31303864
6.
Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.
Blood
; 128(26): 3043-3051, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27793877
7.
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.
Blood
; 127(22): 2711-22, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26917778
8.
Role of Maintenance Therapy after High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation in Aggressive Lymphomas: A Systematic Review.
Biol Blood Marrow Transplant
; 22(7): 1182-1196, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899562
9.
Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
N Engl J Med
; 379(12): 1186, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30260155
10.
Outcome Comparison of Allogeneic versus Autologous Stem Cell Transplantation in Transformed Low-Grade Lymphoid Malignancies: A Systematic Review and Pooled Analysis of Comparative Studies.
Acta Haematol
; 136(4): 244-255, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802434
11.
Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.
Blood
; 131(11): 1258-1261, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437555
12.
Cardioprotective role of ß-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis.
Postgrad Med J
; 91(1081): 627-33, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26399268
13.
Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.
Haematologica
; 99(1): 60-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996484
14.
Transcriptional Plasticity Drives IMiD and p300 Inhibitor Resistance in Multiple Myeloma.
Blood Cancer Discov
; 5(1): 5-7, 2024 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085608
15.
Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Clin Lymphoma Myeloma Leuk
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548563
16.
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.
Blood Adv
; 8(5): 1075-1083, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170740
17.
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis.
Blood Cancer Discov
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713018
18.
Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Hum Pathol
; 136: 1-15, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958463
19.
Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Clin Lymphoma Myeloma Leuk
; 23(3): e150-e163, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624015
20.
Gilteritinib Combined with Azacitidine as Salvage Therapy for B/Myeloid Mixed Phenotype Acute Leukemia.
Cureus
; 14(3): e23618, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35505715